These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 3596463)
1. Crohn's disease. Rifampin treatment of the ocular and gut disease. Wirostko E; Johnson L; Wirostko B Hepatogastroenterology; 1987 Apr; 34(2):90-3. PubMed ID: 3596463 [TBL] [Abstract][Full Text] [Related]
2. Ulcerative colitis associated chronic uveitis. Parasitization of intraocular leucocytes by mollicute-like organisms. Wirostko E; Johnson L; Wirostko B J Submicrosc Cytol Pathol; 1990 Apr; 22(2):231-9. PubMed ID: 2337888 [TBL] [Abstract][Full Text] [Related]
3. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862 [TBL] [Abstract][Full Text] [Related]
4. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study. Omer B; Krebs S; Omer H; Noor TO Phytomedicine; 2007 Feb; 14(2-3):87-95. PubMed ID: 17240130 [TBL] [Abstract][Full Text] [Related]
5. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases]. Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579 [TBL] [Abstract][Full Text] [Related]
6. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Reinisch W; Gasché C; Tillinger W; Wyatt J; Lichtenberger C; Willheim M; Dejaco C; Waldhör T; Bakos S; Vogelsang H; Gangl A; Lochs H Am J Gastroenterol; 1999 Aug; 94(8):2156-64. PubMed ID: 10445543 [TBL] [Abstract][Full Text] [Related]
8. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Prantera C; Zannoni F; Scribano ML; Berto E; Andreoli A; Kohn A; Luzi C Am J Gastroenterol; 1996 Feb; 91(2):328-32. PubMed ID: 8607501 [TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352 [TBL] [Abstract][Full Text] [Related]
10. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875 [TBL] [Abstract][Full Text] [Related]
11. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Korzenik JR; Dieckgraefe BK Aliment Pharmacol Ther; 2005 Feb; 21(4):391-400. PubMed ID: 15709989 [TBL] [Abstract][Full Text] [Related]
17. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease. Chrissafidou A; Malek M; Musch E Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224 [TBL] [Abstract][Full Text] [Related]
18. [Behçet's disease associated with Crohn's disease]. Houman H; Ben Dahmen F; Ben Ghorbel I; Chouaib S; Lamloum M; Kchir N; Ben Ammar A; Miled M Ann Med Interne (Paris); 2001 Nov; 152(7):480-2. PubMed ID: 11965089 [TBL] [Abstract][Full Text] [Related]
19. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease. Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775 [TBL] [Abstract][Full Text] [Related]
20. Effect of steroids on energy expenditure and substrate oxidation in women with Crohn's disease. Al-Jaouni R; Schneider SM; Piche T; Rampal P; Hébuterne X Am J Gastroenterol; 2002 Nov; 97(11):2843-9. PubMed ID: 12425558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]